text: In the present studies, the CB(1) inverse agonist SR141716A (rimonabant) and the << CB(1) >> neutral antagonist [[ AM4113 ]] were compared for their ability to modify CB(1) receptor-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.